J Infect Dis 2006,193(5):617–624 CrossRefPubMed

4 Taha T

J Infect Dis 2006,193(5):617–624.CrossRefPubMed

4. Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LA, Liomba GN, Kumwenda NI, Miotti PG: Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. Aids 1998,12(2):197–203.CrossRefPubMed 5. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG: Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. Aids 1998,12(13):1699–1706.CrossRefPubMed 6. Briselden AM, Hillier SL: Longitudinal study of the biotypes of Gardnerella vaginalis. J Clin Microbiol 1990,28(12):2761–2764.PubMed 7. Cauci S, Driussi S, Monte R, C646 research buy Lanzafame P, www.selleckchem.com/products/Thiazovivin.html Pitzus E, Quadrifoglio F: AZD1152 Immunoglobulin A response against Gardnerella vaginalis hemolysin and sialidase activity in bacterial vaginosis.

Am J Obstet Gynecol 1998,178(3):511–515.CrossRefPubMed 8. McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, Parker R: Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994,170(4):1048–1059. discussion 1059–1060.PubMed 9. Wiggins R, Crowley T, Horner PJ, Soothill PW, Millar MR, Corfield AP: Use of 5-bromo-4-chloro-3-indolyl-alpha-D-N-acetylneuraminic acid in a novel spot test To identify sialidase activity in vaginal swabs from women with bacterial

vaginosis. J Clin Microbiol 2000,38(8):3096–3097.PubMed 10. Hu H, Shioda T, Moriya C, Xin X, Hasan MK, Miyake K, Shimada T, Nagai Y: Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface. Journal of virology 1996,70(11):7462–7470.PubMed 11. Stamatos NM, Gomatos PJ, Cox J, Fowler A, Dow N, Wohlhieter JA, Cross AS: Desialylation of peripheral blood mononuclear cells promotes growth of HIV-1. Virology 1997,228(2):123–131.CrossRefPubMed 12. Fleming DT, Wasserheit JN: From epidemiological synergy Urocanase to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999,75(1):3–17.CrossRefPubMed 13. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J: Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999,180(6):1863–1868.CrossRefPubMed 14. van Esbroeck M, Vandamme P, Falsen E, Vancanneyt M, Moore E, Pot B, Gavini F, Kersters K, Goossens H: Polyphasic approach to the classification and identification of Gardnerella vaginalis and unidentified Gardnerella vaginalis-like coryneforms present in bacterial vaginosis. Int J Syst Bacteriol 1996,46(3):675–682.CrossRefPubMed 15.

Comments are closed.